Literature DB >> 31116699

[Consensus on acute ischemic stroke].

Santiago G Pigretti1, Matías J Alet2, Carlos E Mamani3, Claudia Alonzo4, Martín Aguilar5, Héctor J Alvarez6, Sebastián Ameriso2, María G Andrade3, Florencia Arcondo3, Cristian Armenteros3, José Arroyo6, Ricardo Beigelman4, Pablo Bonardo2, María Bres Bullrich4, Cecilia Cabello7, Gonzalo Camargo8, Sebastián Camerlingo3, Rolando Cárdenas9, Hernán Cháves5, Celina Ciardi2, Nicolás Ciarrochi6, Juan Cirio2, Santiago Claverie2, Pedro Colla Machado2, Marcelo Costilla6, María F Díaz6,4, Daiana Dossi2, María Estrella Gimenez6, Fabiana Giber7, Maia Gómez Schneider2, Leonardo González2, Alejandro Hlavnika6, Pablo Ioli2, Cristian F Isaac2, Andrés Izaguirre4, Francisco Klein6, Pablo Kuschner3, Damián Lerman6, Rossana López6, Victoria Marquevich6, Juan C Miranda9, Margarita Murgieri7, Andrea Odzak3, Perla Pahnke6, Gabriel Persi2,4, José Pizzorno3, Javier Pollan3, Virginia Pujol Lereis2, Flavio Requejo10, Laura Robledo7, Julieta Rosales2, Romina Rubin7, Rodrigo Sabio3, Virginia Tejada Jacob2, Leandro Tumino6, Pascual Valdez3, Walter Videtta6, Andrés Vilela3, Víctor Villaroel Saavedra2, Martín Winkel3, María C Zurrú2,6,4.   

Abstract

Stroke is the third cause of death and the first cause of disability in Argentina. Ischemic events constitute 80% of cases. It requires the implementation of systematized protocols that allow reducing the time of care, morbidity and mortality. Specialists from nine medical societies related to the care of patients with cerebrovascular disease participated in the consensus. A separate agenda was agreed upon in chapters and for the writing of them, work groups were formed with members of different medical specialties. The level of recommendation was discussed and agreed upon for each topic based on the best clinical evidence available for each of them. An adaptation to the local scope of the recommendations was made when it was considered necessary.The American Heart Association system was used to draft the recommendations and their level of evidence. The correction and editing were done by five external reviewers, who did not participate in the writing and with extensive experience in vascular pathology. Once the preliminary document was finalized, a general meeting was held with all the members of the working groups and the reviewers to reach final recommendations. The consensus covers the management of ischemic stroke in the pre-hospital phase, initial evaluation in the emergency center, recanalization therapies (thrombolysis and/ or mechanical thrombectomy), decompressive craniectomy, neuroimaging and clinical care in the hospital.

Entities:  

Keywords:  cerebral infaction; endovascular procedures; infusions; intra-arterial; neuroimaging; stents; stroke; therapeutics

Mesh:

Year:  2019        PMID: 31116699

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  4 in total

1.  Impact of contrast-enhanced transcranial Doppler ultrasound diagnosis for young adult with cryptogenic stroke: A protocol of systematic review.

Authors:  Xiao-Xue Jiang; You Song; Chun-Rong Hu; Li-Hua Wang; Lu Liu; Ya-Juan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

2.  A retrospective study of Yiqi-Huoxue Decoction on blood pressure in patients with acute ischemic stroke.

Authors:  Chao Jiang; Ting Wang; Yong-Cheng Xu; Ying Gao; Bang-Jiang Fang
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

3.  Early Mobilization After Stroke: Do Clinical Practice Guidelines Support Clinicians' Decision-Making?

Authors:  Venesha Rethnam; Kathryn S Hayward; Julie Bernhardt; Leonid Churilov
Journal:  Front Neurol       Date:  2021-02-05       Impact factor: 4.003

Review 4.  A Scoping Review of Non-Pharmacological, Non-Surgical Secondary Prevention Strategies in Ischaemic Stroke and TIA in National Stroke Guidelines and Clinical Audit Documents.

Authors:  Patricia Hall; Lena von Koch; Xu Wang; Olive Lennon
Journal:  Healthcare (Basel)       Date:  2022-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.